A novel machine learning based algorithm to predict 1-year mortality after ventricular tachycardia ablation

3 April 2022 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Peter Vamosi

Semmelweis University, Budapest (Hungary)

131 More presentations in this session

Presentation thumbnail

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Abstract Slides

Presentation thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Doctor G. Stronati (Ancona, IT)

Abstract Slides

Presentation thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Professor D. Lashkul (Zaporizhzhya, UA)

Abstract Slides

Presentation thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Mr E. Abdovic (Zenica, BA)

Abstract Slides

Presentation thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Doctor A. Aro (Helsinki, FI)

Abstract Slides

Access the full session

Session thumbnail

ePosters Day 2

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

You may be interested in

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

Congress Presentation

Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?

Congress Presentation

Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources